Heron Therapeutics, Inc. (HRTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0800 |
| Open | 1.0800 |
| Bid | 1.0100 x 4000 |
| Ask | 1.0200 x 4000 |
| Day's range | 0.9938 - 1.1000 |
| 52-week range | 0.9938 - 4.6800 |
| Volume | |
| Avg. volume | 1,908,729 |
| Market cap | 142.167M |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.0700 |
| Earnings date | 06 Nov 2023 - 10 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.30 |
ZacksHeron Therapeutics (HRTX) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Simply Wall St.Heron Therapeutics, Inc.'s (NASDAQ:HRTX) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures
Key Insights Institutions' substantial holdings in Heron Therapeutics implies that they have significant influence over...
ZacksHeron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -58.82% and 4.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
